$10.53
-0.28%Roman DBDR Acquisition Corp. II operates as a blank check company. It was incorporated for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded on July 25, 2024 and is headquartered in Boca Raton, FL.
No Revenue Data
DRDB has not reported any revenue values in the available annual periods.
DRDB โข NASDAQ
| Roman DBDR Acquisition Corp. II Income Statement | Dec 2025 | Dec 2024 |
|---|---|---|
REVENUE | ||
GROSS PROFIT | ||
OPERATING INCOME | ||
(2.3M) | (206.9K) | |
(2.3M) | (206.9K) | |
-2.3M | -207K | |
PRE-TAX INCOME | ||
9.7M | 317.3K | |
10M | 430.4K | |
7.7M | 223.5K | |
NET INCOME | ||
7.7M | 223.5K |
DRDB - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
8-K 8-K 2026 N/A | June 02, 2026 | May 27, 2026 | 2026 | |
10-Q 10-Q 2026 Q1 Q1 | May 20, 2026 | March 31, 2026 | 2026 | |
8-K 8-K 2026 N/A | May 15, 2026 | May 11, 2026 | 2026 | |
8-K 8-K 2026 N/A | April 28, 2026 | April 22, 2026 | 2026 | |
10-K 10-K 2025 FY FY | March 04, 2026 | December 31, 2025 | 2025 | |
8-K 8-K 2026 N/A | February 27, 2026 | February 27, 2026 | 2026 | |
10-Q 10-Q 2025 Q3 Q3 | November 13, 2025 | September 30, 2025 | 2025 | |
10-Q 10-Q 2025 Q2 Q2 | October 23, 2025 | June 30, 2025 | 2025 | |
8-K 8-K 2025 N/A | October 03, 2025 | September 30, 2025 | 2025 | |
8-K 8-K 2025 N/A | September 18, 2025 | August 28, 2025 | 2025 |
Continue your DRDB research with focused valuation guides.
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.